Tuesday, February 15, 2011

SentiCare Announces FDA Approval on New PillStation Medication Adherence System

SENTICARE, INC. RECEIVES FDA APPROVAL FOR NEW PILLSTATION TELEHEALTH SYSTEM DEVELOPED TO COMBAT CONGESTIVE HEART FAILURE (CHF) & OTHER CHRONIC DISEASE RELATED HOSPITAL READMISSIONS

Company’s New PillStation Medication Adherence System to Be Launched At Annual HIMSS Conference in Orlando From February 20 - 24

Southborough, MA, February 15, 2011 – SentiCare, Inc. today announced FDA
approval for their PillStation, a revolutionary new Medication Adherence Telehealth
System designed to reduce re-hospitalization and doctor visits. Developed with a focus to
significantly lower complications and improve health by assuring medication compliance
with significant cost savings for the healthcare industry, PillStation is designed to combat
CHF and other chronic disease related hospital readmissions. Using patent pending
technology, PillStation transmits images of patient’s medications from within their
PillStation and works with patients on complicated medication regimens to be sure that
patients can self-administer the correct medications at the correct time. The companies
new system will be showcased this month at the 11th annual HIMSS conference and
exhibition (Booth #4005) in Orlando, Florida from February 20 – 24.


The only telehealth system developed which aggregates a list of patient’s prescription
drugs, and provides direct visualization of medication, PillStation’s unique technology
platform provides clear images of the medications being loaded and takes up-to-date
images of the prescriptions after each use. The images, along with other critical data, are
sent to the SentiCare Advisor Center for medications management and monitoring 24
hours a day, seven days a week. Additionally, PillStation provides secure web access for
real-time information regarding adherence and integrates with EMR/PHR services.
Studies show that approximately 29 – 47% of elderly patients with CHF are readmitted
within three to six months of discharge and that approximately 125,000 Americans die
each year due to Medication Non-Adherence, while almost 60% of the prescription
Medication Non-Adherence problems could be prevented. Using proprietary hardware,
software and call center protocols, SentiCare’s state-of-the-art technology is uniquely
developed to address healthcare issues related to Medication Non-Adherence. These
issues, which result in rising cost and risk, especially with patients managing CHF and
other chronic conditions, include:
• Forgetting to take medication
• Discontinuing or taking medication prematurely
• Not filling or refilling a prescription
• Taking incorrect medication
• Taking incorrect dosage
• Taking the right medication at the wrong time
• Double dosing to make up for a skipped dose
• Combining medication with inappropriate food or beverage

PillStation trials have achieved adherence levels on multiple medications of
approximately 98%, compared to an expected baseline in equivalent patients of 40%.
Economic modeling shows that cardiovascular conditions such as CHF are especially
likely to benefit from PillStation in terms of both quality and dramatically lowered
cost. SentiCare’s new telehealth system offers substantial cost savings, which could
result in saving millions of dollars per year, for hospitals, Accountable Care
Organizations (ACOs) and physician groups.

“With recent healthcare reform and the advent of new models for healthcare delivery,
including the establishment of ACOs, Medication Adherence and remote patient
monitoring are emerging as some of the most important areas of healthcare
innovation,” stated company co-founder, Yogendra Jain. “IT models like PillStation,
support new health care delivery systems like ACOs, where the exchange of data is
critical,” he added.

Check out our website for an online product demo video or for more information or a
real time demo on SentiCare’s new PillStation, stop by Booth #4005 at the HIMMS
conference in Orlando from February 20 – 24, or call 603-929-6664 to schedule an
interview. HIMMS is a cause-based, not-for-profit organization exclusively focused
on providing global leadership for the optimal use of information technology (IT) and
management systems for the betterment of healthcare.

About SentiCare
Founded in 2008 and located in Southborough MA, SentiCare has developed a
unique, solution to the serious and costly problem of Medication Non-Adherence.
Using proprietary hardware, software and call center protocols, SentiCare works with
patients on complicated medication regimens to be sure that patients take the correct
medications at the correct time. Proper adherence leads to improved health outcomes,
reduced hospitalization, reduced re-admission within 30-90 days after discharge, and
significant cost savings for Healthcare and Senior Housing Providers. SentiCare’s
approach is unique and targets eight identified attributes that are the root cause of
non-adherence. The PillStation product and service are in full production.
www.senticare.com

No comments:

Post a Comment